Monday, January 7, 2019
Novocure reports Q4 revenue $69.6M, consensus $70.47M
Reports Q4 active patients up 30% from last year at 2.4K and prescriptions received up 21% at 1.3K. Novocure plans to discuss these results with investors at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco.
https://thefly.com/landingPageNews.php?id=2844977
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.